Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Health Policy (Amsterdam, Netherlands)|August 2, 2011
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010Sylvain Pichetti, Christine Sorasith, Catherine Sermet
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 16, 2014
Entry time effects and follow-on drug competitionLuiz Flavio Andrade, Catherine Sermet, Sylvain Pichetti
European Journal of Clinical Pharmacology|June 12, 2017
Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French populationMarie Herr, Nicolas Sirven, Hélène Grondin, et al.
Applied Health Economics and Health Policy|April 24, 2013
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in FranceSylvain Pichetti, Catherine Sermet, Brian Godman, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|December 27, 2022
Dorian Verboux, Martine Thomas, Nadine Colinot, et al.
Pageof 1